RAPID•ID™ is the Cure for Medical Plastics Quality Control
|
|||||||||||||||||
By Mike Kayat, Intevac Photonics, DeltaNu The global medical plastics industry is growing at an increasing annual volume. Industry drivers are principally the development of new medical devices that replace metal parts with advanced polymers, the increased use of these devices for an increasing number of longer living patients in both developed and emerging countries, and the move to disposable products. The increasing availability of portable, point of care devices is also a key development driving home-based diagnostic applications. About three-quarters of the medical plastics market is comprised of pharmaceutical and biological products, the rest of the market is made up of surgical appliances and medical instruments. How large is the market for medical plastics? For the US, recent research reports estimate that by 2011, over 3 billion pounds of medical grade plastics will be utilized, growing to over 4 billion pounds in 2015. Globally, some 15 billion pounds will be consumed in 2015, as both developed and emerging countries use more medical devices. Commodity resins including PE, PP, PVC, PS and PET, make up over 50% of medical plastics used, engineering plastics including nylon, PC, ABS come in at about 15% with thermoplastic elastomers such as TPU, TPV and SBC making up the rest. A wide range of additives are typically used in compounds. Stringent Quality Control Requirements Patient safety drives the adoption of government regulations. Medical grade plastics must be long lasting, be able to be sterilized with radiation, exhibit blood compatibility, particularly antithrombotic activity and other characteristics which are symbiotic with the human environment. In the US, the FDA mandates close communications between manufacturers and suppliers. However, problems can be created when even slight changes are made in approved materials. Timely incoming inspection of raw materials, by manufacturers is a critical step in ensuring a rigorous QA/QC process, to avoid potential brand damage with high recall costs. Now, there is an easy, cost-effective, palm-sized solution that significantly reduces the incidence of misidentification: RAPID•ID™, designed by DeltaNu (www.deltanu.com), the leader in handheld materials identification instruments. This tool has been used to support FDA mandated QA/QC processes within the medical plastics industry, along with other industries.
Additives and Counterfeits A number of additives are typically included in medical plastics products during the molding or extrusion processes. These include: anti-static agents, lubricants, plasticers and stabilizers. These may be contaminated or have variable concentrations, leading to adverse effects when used in end user environments. A quick, reliable approach is required to identify these additives and confirm or otherwise, their presence in target materials. Another major issue facing manufacturers concerns counterfeit materials. Recent product recalls cite a range of counterfeit medical plastics components that were initially difficult to detect and identify. Once again, a quick, reliable solution is needed to isolate counterfeit parts and materials. Authentification using Taggants With a focus on enhanced security solutions to prevent counterfeit activities, along with more sensitive QA/QC control, several companies have developed microscopic chemically active materials now called taggants. These taggants can be uniquely encoded and added to a wide range of dry and wet product materials. Taggants can be used for a yes/no or pass/fail identification procedure, or for verifying that certain materials have not been substituted or diluted, or are missing altogether. One company, Microtrace, LLC. (www.microtracesolutions.com), manufactures several different types of taggants ranging from microscopic particles called Microtaggant® to taggants which are completely soluble and invisible, which are called Molecular taggants. Microtrace supplies its taggants to the plastics industry in two delivery formats. For the compounder or masterbatcher, the Microtaggants are delivered in a dry particle form while the Molecular taggant is delivered as a masterbatch concentrate. For the plastic processor, both the Microtaggant and Molecular taggant are delivered in a finished masterbatch per specification, ready for processing typically at a standard 1% - 2% let down rate. Figure 3, shows a typical Microtaggant material that can be added to a typical resin masterbatch, shown in Figure 4. Microtrace taggants enable finished products to contain covert authentification capabilities for product security and brand protection.
|
|
||||||||||||||||
| Products - Advertising - About - Contact | ©1986- IDES |